That was among the many special moments for 11-year-old Cooper Trueblood at the Washington Capitals’ annual Hockey Fights ...

The Food and Drug Administration (FDA) has approved Aucatzyl ® (obecabtagene autoleucel; obe-cel) for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in ...

Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...

A mother who claims her GP said her four-year-old daughter was “faking it” a week before she was diagnosed with a ...

Autolus Therapeutics has secured US Food and Drug Administration (FDA) approval for Aucatzyl (obecaktagene autoleucel), its ...

Syncona's Chief Executive Officer Chris Hollowood said: "We are delighted for Autolus to receive FDA approval for its novel CAR T-cell therapy for the treatment of adult ALL. Adult ALL is a ...

Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with ...

Syncona Ltd (SYNC.L) said that its portfolio company Autolus Therapeutics announced that the U.S. Food and Drug Administration has ...

Prior to this, Summer, from Hampshire, had been "constantly poorly" and bruising easily. However, when Rebecca, 33, took her ...